AI-Powered Remote Cardiac Monitoring Improves Care Access, Disease Detection, and Diagnostic Accuracy
AI-powered remote cardiac monitoring technology from InfoBionic.AI is transforming cardiovascular care by enabling continuous, near real-time detection of arrhythmias and reducing false positives for atrial fibrillation by over 85%. The platform leverages algorithms developed in collaboration with Mayo Clinic and streams data to the cloud for physician review. It also improves health equity by eliminating the need for in-person visits, expanding care access to rural and underserved populations.
This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.
Promoted content from I Don't Care on MarketScale.
Key takeaways
InfoBionic.AI's AI platform reduces false positives for atrial fibrillation by over 85%, delivering cleaner diagnostic data to clinicians.
Continuous cloud-based monitoring processes millions of heartbeats in near real-time, prioritizing critical information for physicians.
Remote cardiac monitoring removes barriers to in-person visits, improving care access for patients in rural and underserved areas.
Free workspace
Turn your Healthcare expertise into content.
Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.
Advancements in artificial intelligence are transforming healthcare, and remote cardiac monitoring is at the forefront of this change. With cardiovascular disease impacting nearly 50% of the population at some point in their lives, early detection and efficient diagnosis are crucial. Enter AI-powered cardiac monitors that provide near real-time data, reduce diagnostic errors, and improve access to care. But how exactly does this technology work, and what does it mean for patients and healthcare providers?
Welcome to I Don't Care. In this episode, Dr Kevin Stevenson sits down with Stuart Long, the CEO of InfoBionic.AI, to explore the transformative impact of AI on cardiac monitoring. From continuous monitoring that detects arrhythmias in real-time to algorithms developed in collaboration with Mayo Clinic, this conversation addresses a vital question: How can technology redefine the landscape of cardiac care?
Key Points of Discussion:
- Continuous Monitoring Revolution: InfoBionic's device streams data to the cloud, using AI to process millions of heartbeats and prioritize critical information for physicians.
- Reducing False Positives: By leveraging advanced AI and signal processing, the company has reduced false positives for atrial fibrillation by over 85%, providing clinicians with cleaner, more actionable data. By leveraging advanced AI and signal processing, the company has reduced false positives for atrial fibrillation by over 85%, providing clinicians with cleaner, more actionable data.
- Improving Health Equity: With remote cardiac monitoring solutions that eliminate the need for in-person visits, InfoBionic ensures greater access to cardiac care, especially in rural areas.
Stuart Long is a seasoned healthcare executive with over 30 years of experience leading and scaling companies in the medical device and healthcare IT sectors. As CEO of InfoBionic.AI, he has pioneered advancements in AI-powered cardiac monitoring, significantly improving diagnostic accuracy and patient outcomes. With expertise in enterprise software, medical imaging, and strategic operations, Long also brings a strong background in marketing strategy, honed at Cornell University's Johnson Graduate School of Management.
Part of this channel
I Don't Care
Candid healthcare leadership conversations with Kevin Stevenson
Your experts belong here
Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.
Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.
About the author
